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The PI3K-Mediated Activation of CRAC
Independently Regulates Adenylyl Cyclase
Activation and Chemotaxis
even after extended exposure to the chemoattractant
(Figure 1A). To characterize this behavior at the cellular
level, we visualized how cells respond to a point source
of chemoattractant that is delivered with a micropipette.
Here, again, we found that crac cells show reduced
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2PRAT (Pharmacology Research Associate chemotaxis. Within minutes after being exposed to the
gradient, wild-type Ax3 cells rapidly align and migrateTraining) Research Fellowship Program
National Institute of General Medical Sciences to the tip of the micropipette. Cells lacking CRAC, on
the other hand, show much slower movement, barelyNational Institutes of Health
Bethesda, Maryland 20892 moving one cell length during the 12 min recording,
compared to 4 cell length for wild-type cells (Figure
1B, Movies 1 and 2, and Figure S2 for DIAS analysis).
Although the crac cells do eventually polarize and ori-Summary
ent toward the tip of the micropipette, they display a
broad front and do not form streams of cells aligned inThe ability of a cell to detect an external chemical
a head-to-tail fashion, compared to wild-type cells.signal and initiate a program of directed migration
To investigate whether the chemotaxis defect of thealong a gradient comprises the fundamental process
crac cells is due to a fundamental defect in the mobili-called chemotaxis [1]. Investigations in Dictyostelium
zation of actin, we measured chemoattractant-depen-discoideum and neutrophils have established that
dent actin polymerization. We observed that, like wild-pleckstrin homology (PH) domain-containing proteins
type cells, crac cells show a rapid peak of corticalthat bind to the PI3K products PI(3,4)P2 and PI(3,4,5)P3,
F-actin accumulation (within 5 s) upon stimulation (Fig-such as CRAC (cytosolic regulator of adenylyl cyclase)
ure 1C), demonstrating that crac cells can mobilizeand Akt/PKB, translocate specifically to the leading
the actin cytoskeleton in a chemoattractant-dependentedge of chemotaxing cells [2–4]. CRAC is essential for
manner. Indeed, in agreement with previous work show-the chemoattractant-mediated activation of the ade-
ing that crac cells exhibit normal orientation whennylyl cyclase ACA [5], which converts ATP into cAMP,
placed in a chemoattractant gradient, we also find thatthe primary chemoattractant for D. discoideum. The
crac cells are able to polarize in response to chemoat-mechanisms by which CRAC activates ACA remain to
tractant stimulation [6] (Figure 1B andMovie 2). Interest-be determined. We now show that in addition to its
ingly, when we measure the extent by which chemoat-essential role in the activation of ACA, CRAC is in-
tractants can polymerize actin as a function of time, wevolved in regulating chemotaxis. Through mutagene-
find that crac cells do not display the second phase ofsis, we show that these two functions are indepen-
actin polymerization at approximately 120 s poststimu-dently regulated downstream of PI3K. A CRACmutant
lation,whichhas beenproposed toplay a role in pseudo-that has lost the capacity to bind PI3K products does
pod extension and chemotaxis (Figure 1D) [7]. Takennot support chemotaxis and shows minimal ACA acti-
together, these findings show that the chemotaxis de-vation. Finally, overexpression of CRAC and various
fects of crac cells are not due to alterations in theCRAC mutants show strong effects on ACA activation
motility machinery but, instead, to defects in translatingwith little effect on chemotaxis. These findings estab-
the external chemoattractant gradient into directedlish that chemoattractant-mediated activation of PI3K
pseudopod extension and subsequent directed migra-is important for the CRAC-dependent regulation of
tion. Furthermore, these results establish that, similarboth chemotaxis and adenylyl cyclase activation.
to RasC, AleA (a RasGEF), and the cytosolic regulator
Pianissimo, CRAC has at least two functions [8–11].
Results and Discussion Namely, in addition to its established role in adenylyl
cyclase activation, CRAC is also involved in regulating
CRAC Regulates Chemotaxis chemotaxis.
To assesswhetherCRAC (cytosolic regulator ofadenylyl
cyclase) is required for chemotaxis, cells lacking CRAC
(crac) [5] were starved and allowed to differentiate to CRAC Regulates Adenylyl Cyclase
the chemotaxis competent stage [2], as judged byWest- and Chemotaxis Independently
ern blot analysis of early developmental markers, such In order to begin to understand the mechanisms by
as the chemoattractant receptor cAR1 (Figure S1 in the which CRAC regulates the activation of both adenylyl
Supplemental Data available with this article online). The cyclase and chemotaxis, we generated and character-
chemotactic behavior of a large population of cells was ized a series of C-terminal deletion mutants (C-CRAC,
measured by the under-agarose chemotaxis assay. We Figure 2A), including the synag7 deletion mutant, which
observed that, in contrast to wild-type Ax3 cells, crac was previously isolated from a chemical mutagenesis
cells do not move toward the chemoattractant source, screen and shown to be defective in adenylyl cyclase
activation [12]. The various CRAC mutants were fused
to either HA (at the N terminus) or GFP (at theC terminus)*Correspondence: parentc@helix.nih.gov
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Figure 1. CRAC Regulates Chemotaxis
(A) Under-agarose chemotaxis assay. Differentiated wild-type Ax3 and crac cells were plated into wells on either side of a well containing
1 M cAMP. Images were taken with a Leica DM IL stereoscope 45 min after the cells were plated. Chemotaxing cells exit from the well and
migrate under the agarose, appearing as a halo outside the perimeter of the well. Data are representative of results obtained from at least 6
independent experiments, each performed in triplicate.
(B) Chemotaxis to a point source of chemoattractant. Images of differentiated wild-type Ax3 (top panels and Movie 1) and crac cells (bottom
panels and Movie 2) migrating to a micropipette filled with 10 M cAMP are shown. We could not measure any significant movement from
the crac cells in the presence of 1 M cAMP, although wild-type cells responded very well to this concentration. Images representative of
at least five independent experiments are shown.
(C and D) Actin polymerization response in response to chemoattractant stimulation. (C) Differentiated cells were plated onto 8-well chambered
coverslips, stimulated with 10 M cAMP, fixed at the indicated time points, and then F-actin was visualized by Texas-Red-X phalloidin.
Montages of two representative cells presented for each time point. (D) Differentiated cells were stimulated with 10 M cAMP and, at the
indicated time points, aliquots were removed and fixed in potassium phosphate-PIPES buffer containing TRITC-phalloidin. Labeled actin was
extracted with MeOH and fluorescence intensity was measured in a spectrofluorimeter. SEM values are presented from four independent
experiments.
and expressed in crac cells. The resulting cell lines lying CRAC’s role during chemotaxis are distinct from
those involved in regulating adenylyl cyclase activation.were allowed to differentiate and were processed through
a battery of biological and biochemical analyses. We
found that, like crac cells, all of the C-CRAC mutants PI3K Products Regulate Chemotaxis and Adenylyl
Cyclase Activationfail to aggregate when plated on non-nutrient agar (data
not shown) and are defective in chemoattractant-medi- The PH (pleckstrin homology) domain of CRACcan bind,
in vitro, to the 3-phosphoinositides PI(3,4,5)P3 andated activation of adenylyl cyclase (Figure 2B). Never-
theless, the C-CRAC mutants can translocate to the PI(3,4)P2, the lipid products of PI3K [15].We thus charac-
terized a series of CRAC PH domain constructs in orderplasmamembranewhenstimulatedwith a uniform, satu-
rating dose of chemoattractant, as judged by fluores- to assess the role of PI3K in chemoattractant-mediated
CRAC signaling. Here again the various PH mutantscence microscopy and Western blot analysis of mem-
brane preparations (Figure 2C). In addition, all of the were fused toGFP to allowmicroscopic characterization
of the translocation. We found that, similar to other PHC-CRAC mutants are capable of rescuing the crac
chemotaxis defect, as judged by both the micropipette domains [1], the CRAC PH domain alone (PHCRAC) ex-
pressed in crac cells is sufficient to mediate membraneand the under-agarose assays (Figure 2D). Cells that
lack adenylyl cyclase can chemotax but cannot relay targeting upon either a uniform, saturating dose of che-
moattractant or in a gradient of chemoattractant sup-the chemoattractant signal to distal cells. As a result,
they do not organize in head to tail fashion in long plied by a micropipette (Figure S3). In spite of its proper
localization in response to chemoattractant, PHCRAC doesstreams of cells during chemotaxis [13, 14]. Likewise,
theC-CRACmutant-expressing cells, which are defec- not rescue the chemotaxis defect of crac cells (Figure
S3) and crac cells expressing PHCRAC have no detect-tive in the capacity to activate adenylyl cyclase, do not
streamduring chemotaxis (Figure 2D andMovie 3). From able adenylyl cyclase activation following chemoattrac-
tant stimulation (data not shown). These results demon-these studies, we conclude that the determinants under-
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Figure 2. CRAC Regulates Adenylyl Cyclase and Chemotaxis Independently
(A) Schematic representation of CRAC C-terminal deletion (C-CRAC) mutants.
(B) C-CRAC mutants do not activate adenylyl cyclase. Adenylyl cyclase activity was measured after the addition of 10 M cAMP in crac
cells expressing either wild-type CRAC or C-CRAC mutants. Data are representative of results from three to four independent experiments,
each performed in duplicate.
(C) C-CRAC mutants translocate to the plasma membrane upon chemoattractant stimulation. In the top panels, differentiated cells were
stimulated with 10 M cAMP and visualized microscopically, either live or after fixation 5 s poststimulation. For the biochemical translocation
assay (bottom panel), cells were stimulated with cAMP and, at the indicated time points, aliquots were removed, diluted with cold buffer, and
the membrane fractions were collected by centrifugation. Membrane fractions were analyzed by immunoblotting with either anti-GFP or anti-
HA antibodies, depending on the construct. Results shown are for the synag7 deletion mutant and are representative of all of the C-CRAC
mutants tested.
(D)C-CRACmutants can support chemotaxis. Chemotaxis of crac cells expressingC-CRACmutantswas assessed by both themicropipette
assay (top panel and Movie 3) and the under-agarose assay (bottom panel) as described in the legend of Figure 1. The C-CRAC mutants
show chemotaxis in both assays but do not organize in a head-to-tail fashion in long streams as wild-type cells do. Results shown are for
the synag7 deletion mutant and are representative of all of the C-CRAC mutants tested.
strate that, although the PH domain is responsible for To examine more specifically the role of 3-phospho-
inositides inCRAC function,we introduced apointmuta-CRAC’s recruitment to the plasma membrane, it does
not contain the information required to mediate chemo- tion into the predicted 3-phosphoinositide binding motif
[16]within theCRACPHdomain (R42C-CRAC).Wedem-taxis or to activate adenylyl cyclase on its own. More-
over, because we observed normal translocation kinet- onstrate that this point mutant fails to bind to 3-phos-
phoinositides in vitro (Figure 3A). As with PH-CRAC,ics, these findings show that the regulation of the PI3K/
PTEN signaling cascade is intact in crac cells. wewere unable todetect cAMPstimulated translocation
of R42C-CRAC to the plasma membrane, either by fluo-To further test the role of the PH domain in CRAC
function, we generated a mutant with a deletion of the rescence microscopy or Western blot analysis of mem-
brane fractions (Figure 3B). In addition, the R42C-CRACentire PH domain (PH-CRAC) and expressed it in crac
cells. We were unable to detect chemoattractant-medi- point mutant failed to support chemotaxis in either the
micropipette assay (Figure 3B andMovie 4) or the under-ated recruitment ofPH-CRAC to theplasmamembrane
(Figure S4), further confirming that the PH domain alone agarose assay (Figure 3B), even after extended expo-
sure to the chemoattractant gradient. This finding dem-is a primary determinant of CRAC recruitment to the
plasmamembrane. Similarly, PH-CRAC did not rescue onstrates that 3-phosphoinositide binding is essential
for CRAC-mediated regulation of chemotaxis. Interest-either the chemotaxis defect (Figure S4) or the adenylyl
cyclase defect of crac cells (Figure 3C). These results ingly, we also find that the R42C-CRAC point mutant
only partially rescues the adenylyl cyclase defects ofshow that the PH domain of CRAC is essential for all of
its known chemoattractant-stimulated functions, namely, crac cells (Figure 3C), suggesting that 3-phosphoinosi-
tide binding is important for CRAC-mediated activationmembrane recruitment, chemotaxis, and adenylyl cy-
clase activation. of adenylyl cyclase. These findings have two implica-
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Figure 3. PI3K Products Regulate Chemotaxis and Adenylyl Cyclase Activation
(A) Dot blot assays for phosphoinositide binding. Supernatants of crac cells expressing GFP fusions of either wild-type CRAC (left panel) or
R42C-CRAC (right panel) were incubated with dot blots containing a variety of lipids, as indicated in the key to the right. Both supernatants
expressed comparable levels of protein, as judged by Western analysis. Bound proteins were detected with anti-GFP antibody.
(B) Chemotaxis and translocation of R42C-CRAC/crac cells. The R42C-CRAC mutant fails to support chemotaxis in either the micropipette
assay (top panels and Movie 4) or the under agarose assay (bottom panel). In the micropipette assay, the micropipette (indicated by the
arrow) was not moved for the duration of the 13 min video. Note the lack of translocation of the R42C-CRAC to the side of the cell facing the
chemoattractant source. The under-agarose assay was carried out for extended times (2 hr) to verify the chemotaxis defective phenotype of
R42C-CRAC. With this extended duration, wild-type cells form very long streams of cells migrating toward the chemoattractant source. For
the biochemical translocation assay (middle panel), cells were stimulated with 10 M cAMP and membrane preparations analyzed as described
in the legend of Figure 2. The results are representative of at least three independent experiments.
(C) Adenylyl cyclase activity in CRAC PH domain mutants. Differentiated cells were stimulated with cAMP and processed for adenylyl cyclase
activity measurements as described in the legend of Figure 2. The graph is representative of at least six independent experiments, each
performed in duplicate.
(D) Myr-CRAC is degraded upon the initiation of differentiation. Images show the distribution and presence of Myr-CRAC-GFP expressed in
crac cells at different times after the initiation of differentiation. A larger field is presented for the 120 min time showing a larger number of
cells, indicating a widespread loss of Myr-CRAC-GFP (phase image on right). The bottom panel shows Western blot detection of Myr-CRAC-
GFP at various time points after the start of differentiation.
tions. First, they establish that PI3K activity is required ized and degraded upon the initiation of differentiation
(Figure 3D), therefore precluding us from assessing thefor maximal chemoattractant-mediated stimulation of
adenylyl cyclase, as observed for relaxin-mediated ade- effects of constitutive membrane targeting of CRAC in
chemotaxis-competent cells. Nevertheless, these re-nylyl cyclase activation in a monocyte cell line [17]. Sec-
ond, our findings show that the CRAC determinants that sults raise the interesting possibility that the recruitment
of CRAC to the plasma membrane initiates a programindependently regulate chemotaxis and adenylyl cy-
clase activation are downstream of PI3K. of regulated CRAC turnover.
In order to further assess the requirements for the
membrane recruitment of CRAC for adenylyl cyclase Overexpression of CRAC and CRAC Mutants
Alters Chemoattractant Signalingactivation, we fused CRAC to the src myristoylation
(Myr) sequence, which has previously been used for We reasoned that, because CRAC is important for multi-
ple aspects of chemoattractant signaling, the overex-targeting proteins to the plasma membrane [18]. This
Myr-CRAC fusion protein showed constitutive mem- pression of CRAC inwild-type Ax3 cells could also affect
a variety of signaling pathways. We found that the over-brane localization in undifferentiated cells. Remarkably,
we found that the Myr-CRAC protein is rapidly internal- expression of wild-type CRAC dramatically increases
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Figure 4. Overexpression of CRAC and CRAC Mutants Alters Chemoattractant Signaling to Adenylyl Cyclase
(A) Adenylyl cyclase activity in wild-type Ax3 cells expressing wild-type CRAC. To allow us to visually monitor the expression of our constructs,
we used GFP fusions for these experiments. We overexpressed CRAC in wild-type cells, selecting for transformants at G418 concentrations
of 5, 20, and 40 g/ml. Cells were assayed for chemoattractant-stimulated adenylyl cyclase activation as described in the legend of Figure
2. The inset shows an anti-GFP Western blot demonstrating the relative expression level of CRAC-GFP at each dose of G418.
(B) Under-agarose chemotaxis assays of wild-type cells expressing CRAC and CRAC PH mutant constructs. These transformants were
generated using 40 g/ml G418. In each case, the untransfected wild-type cells are in the top well and the transfected cells are in the bottom
well. Each experiment was performed at least three times in triplicate.
(C) Adenylyl cyclase activity in wild-type cells expressing the indicated CRAC constructs. Cells were assayed for chemoattractant-stimulated
adenylyl cyclase activation as described in the legend of Figure 2. The inset shows an anti-GFP Western blot demonstrating the relative
expression level of each construct.
the extent of adenylyl cyclase activation in response to quence (data not shown), the overexpression of the
R42C-CRAC has a dominant positive effect (Figure 4C)chemoattractant (Figure 4A). Interestingly, we also find
that CRAC overexpression does not have an apparent and the PH-CRAC mutant produced the opposite ef-
fect, showing a dominant negative suppression of ade-effect on chemotaxis (Figure 4B). We conclude that
CRAC or a CRAC-interacting factor is limiting for ade- nylyl cyclase activation (Figure 4C). From these results,
we infer that adenylyl cyclase regulation requires thenylyl cyclase activation but not for chemotaxis. These
results are consistent with our previously reported stud- interaction of multiple factors with both the C-terminal
region and the N-terminal PH domain, independent ofies showing that ACA is not required for chemotaxis [14].
To further characterize theCRACPHdomain, weover- the 3-phosphoinositide binding site. As shown for a vari-
ety of other PH domain-containing proteins, these ob-expressed various PH domain mutants in wild-type Ax3
cells and analyzed CRAC-dependent processes. Like servations also imply that, in addition to binding to lipid
products of PI3K, the PH domain takes part in otherwild-type CRAC, none of the overexpressed PH-domain
mutants has a dramatic effect on chemotaxis, although interactions that are critical for CRAC function [19]. We
propose that the dominant positive effect of overex-cells expressing PH-CRAC routinely display less ro-
bust movement and PHCRAC expressed in wild-type cells pressedR42C-CRAC involves its binding tomultiple fac-
tors that target and activate the adenylyl cyclase signal-have polarity defects (Figure 4B and data not shown).
On the other hand, overexpression of some PH domain ing complex. In contrast, the dominant negative effect
of overexpressed PH-CRAC involves its binding andmutants leads to interesting effects on chemoattractant-
mediated activation of adenylyl cyclase. While the over- sequestration or inactivation of essential factors that
interact with the C-terminal region. We suggest that theexpression of the PH domain alone has no major conse-
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solic regulator, Pianissimo, is required for chemoattractant re-translocation of the CRAC complex initiates a series of
ceptor and G protein-mediated activation of the 12 transmem-events that ultimately lead to the full activation of ACA.
brane domain adenylyl cyclase in Dictyostelium. Genes Dev.In support of this hypothesis, we show here that R42C-
11, 3218–3231.
CRAC, which fails to bind to 3-phosphoinositides and 12. Theibert, A., andDevreotes, P.N. (1986). Surface receptor-medi-
displays no measurable plasma membrane association, ated activation of adenylate cyclase in Dictyostelium. Regula-
tion by guanine nucleotides in wild-type cells and aggregationconfers minimal ACA activation when expressed in
deficient mutants. J. Biol. Chem. 261, 15121–15125.crac cells. In addition, pten cells, which showan exag-
13. Pitt, G.S., Milona, N., Borleis, J., Lin, K.C., Reed, R.R., andgerated and prolonged duration of CRAC translocation,
Devreotes, P.N. (1992). Structurally distinct and stage-specificdisplay sharply increased chemoattractant-dependent
adenylyl cyclase genes play different roles in Dictyostelium de-
activation of ACA [20]. Taken together, these results velopment. Cell 69, 305–315.
suggest that CRAC is a central regulator that mediates 14. Kriebel, P.W., Barr, V.A., and Parent, C.A. (2003). Adenylyl cy-
clase localization regulates streaming during chemotaxis. Cellthe action of multiple effectors of chemoattractant sig-
112, 549–560.naling.
15. Huang, Y.E., Iijima, M., Parent, C.A., Funamoto, S., Firtel, R.A.,
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